Proteomic profiling reveals that collismycin A is an iron chelator-Reference-Cited by-同舟云学术

Proteomic profiling reveals that collismycin A is an iron chelator

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Kawatani Makoto,Muroi Makoto,Wada Akira,Inoue Gyo,Futamura Yushi,Aono Harumi,Shimizu Kenshirou,Shimizu Takeshi,Igarashi Yasuhiro,Takahashi-Ando Naoko,Osada Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep38385.pdf

Reference41 articles.

1. Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J. Nat. Prod. 75, 311–335 (2012).

2. Osada, H. Development and application of bioprobes for mammalian cell cycle analyses. Curr. Med. Chem. 10, 727–732 (2003).

3. Futamura, Y., Muroi, M. & Osada, H. Target identification of small molecules based on chemical biology approaches. Mol. Biosyst. 9, 897–914 (2013).

4. Kawatani, M. & Osada, H. Affinity-based target identification for bioactive small molecules. MedChemCommun 5, 277–287 (2014).

5. Kawatani, M. et al. The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I. Proc. Natl. Acad. Sci. USA 105, 11691–11696 (2008).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and characterization of the siderochelin biosynthetic gene cluster via coculture;mBio;2024-08-27

2. Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole;Microbiology Spectrum;2024-01-17

3. Natural transaminase fusions for biocatalysis;RSC Advances;2024

4. Source, Synthesis, and Biological Evaluation of Natural Occurring 2,2′‐Bipyridines;Chemistry & Biodiversity;2023-12

5. Characterization of a selective, iron-chelating antifungal compound that disrupts fungal metabolism and synergizes with fluconazole;2023-08-09